# Survival expectations in melanoma patients: a molecular prognostic model associated with aging

**Authors:** Nenghua Zhang, Xinyi Qiu, Xingying Chen, Cheng Du, Jingyi Dong, Xiaohong Li, Bing Chen, Lin Zhang, Yuyan Zhang

PMC · DOI: 10.1007/s12672-025-01971-z · Discover Oncology · 2025-02-28

## TL;DR

This study identifies a molecular model using aging-related lncRNAs to predict survival in melanoma patients, showing better performance than traditional clinical features.

## Contribution

The study introduces a novel lncRNA-based prognostic model linking melanoma survival to aging-related molecular signatures.

## Key findings

- Five lncRNA signatures (AC011481.1, USP30-AS1, EBLN3P, LINC01527, HLA-DQB1-AS1) were associated with overall survival in melanoma.
- Reduced EGFR and increased ATF2 and POLD1 expression correlated with worse prognosis in melanoma patients.
- Aging-related lncRNAs were enriched in pathways like reactive oxygen metabolism, ferroptosis, immunity, and autophagy in melanoma.

## Abstract

Aging and long non-coding RNAs (lncRNAs) are research hotspots in melanoma. However, no study has so far explored the relationship between melanoma prognosis and aging-related lncRNAs (ARLs).

The Cancer Genome Atlas database, the GTEx database, and the HAGR database were used in this study in a combined manner. Univariate and multivariate cox regression analyses were used to screen out lncRNA signatures associated with overall survival (OS) in the primary dataset. The risk scoring model was analyzed by risk stratification and tested internally. The protein expression levels of possible target genes of ARLs were verified by immunohistochemistry analysis in HPA database. Finally, gene enrichment analysis was performed.

In the primary dataset, five OS-related lncRNA signatures (AC011481.1, USP30-AS1, EBLN3P, LINC01527, HLA-DQB1-AS1) were screened out. The survival curve showed that the high-risk group had a worse prognosis than the low-risk group. The immunohistochemical analysis revealed that reduced expression of Epidermal Growth Factor Receptor (EGFR), along with increased expression of Activating Transcription Factor 2 (ATF2) and DNA Polymerase Delta 1 (POLD1), was linked to a worse prognosis. Finally, enrichment analysis revealed that OS-related DELs were significantly enriched in the regulation of reactive oxygen metabolism, etc. The ARGs were significantly activated in the SKCM tissues. The regulation of aging in melanoma cells may be realized through ferroptosis, immunity, and autophagy and so on.

The ARL signature obtained in this study had better prognostic ability than individual clinical features.

The online version contains supplementary material available at 10.1007/s12672-025-01971-z.

## Linked entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956], ATF2 (activating transcription factor 2) [NCBI Gene 1386], POLD1 (DNA polymerase delta 1, catalytic subunit) [NCBI Gene 5424]
- **Diseases:** melanoma (MONDO:0005105)

## Full-text entities

- **Genes:** HLA-DQB1 (major histocompatibility complex, class II, DQ beta 1) [NCBI Gene 3119] {aka CELIAC1, HLA-DQB, IDDM1}, SERPINA2 (serpin family A member 2 (gene/pseudogene)) [NCBI Gene 390502] {aka ARGS, ATR, PIL, SERPINA2P, psiATR}, LINC01527 (long intergenic non-protein coding RNA 1527) [NCBI Gene 101927988] {aka lnc-SPRR2D-1}, POLD1 (DNA polymerase delta 1, catalytic subunit) [NCBI Gene 5424] {aka CDC2, CRCS10, IMD120, MDPL, POLD}, ATF2 (activating transcription factor 2) [NCBI Gene 1386] {aka CRE-BP1, CREB-2, CREB2, HB16, TREB7}, USP30 (ubiquitin specific peptidase 30) [NCBI Gene 84749], EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, EBLN3P (endogenous Bornavirus like nucleoprotein 3, pseudogene) [NCBI Gene 100506710] {aka EBLN3}
- **Diseases:** melanoma (MESH:D008545), HPA (MESH:D010661), Cancer (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11874052/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11874052/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC11874052/full.md

---
Source: https://tomesphere.com/paper/PMC11874052